News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Regeneron Pharmaceuticals, Inc. (REGN) Announces Upcoming 2013 Investor Conference Presentations


2/19/2013 8:12:40 AM

TARRYTOWN, N.Y., Feb. 19, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations at the following investor conferences:

  • Citi 2013 Global Healthcare Conference; Dyslipidemia Panel on Tuesday, February 26, 2013. The session is scheduled for 1:30 p.m. Eastern Time.
  • RBC Capital Markets' 2013 Global Healthcare Conference on Wednesday, February 27, 2013. The presentation is scheduled for 9:30 a.m. Eastern Time.
  • Barclays Global Healthcare Conference on Tuesday, March 12, 2013. The presentation is scheduled for 2:30 p.m. Eastern Time.

The sessions may be accessed through the Company's web site, www.regeneron.com, on the 'Events and Presentations' page. An archived version of the presentations will be available for 30 days.

About Regeneron Pharmaceuticals, Inc.
Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, rheumatoid arthritis, and asthma. For additional information about the company, please visit www.regeneron.com.

Contact Information:




Michael Aberman, M.D.

Peter Dworkin

Investor Relations

Corporate Communications

914.847.7799

914.847.7640

michael.aberman@regeneron.com

peter.dworkin@regeneron.com

SOURCE Regeneron Pharmaceuticals, Inc.


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES